Stay updated on Safety & Metabolic Profile of Vyvanse in ADHD & Bipolar Adults Clinical Trial
Sign up to get notified when there's something new on the Safety & Metabolic Profile of Vyvanse in ADHD & Bipolar Adults Clinical Trial page.

Latest updates to the Safety & Metabolic Profile of Vyvanse in ADHD & Bipolar Adults Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision updated from v3.3.1 to v3.3.2. No changes to the study details or page content are visible.SummaryDifference0.1%

- Check21 days agoChange DetectedThe page shows a revision update from v3.2.0 to v3.3.1; no substantive study content changes are evident. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check29 days agoChange DetectedRemoved the funding/operating status notice that previously warned about updates; the core study details remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check43 days agoChange DetectedThe new screenshot shows minor formatting and layout adjustments on the Study Details page, with no changes to core content such as eligibility criteria, primary outcomes, or contacts. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check71 days agoChange DetectedMajor update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.SummaryDifference5%

- Check79 days agoChange DetectedVersion bump from v3.0.2 to v3.1.0. This signals a software update; no other content changes are indicated.SummaryDifference0.1%

Stay in the know with updates to Safety & Metabolic Profile of Vyvanse in ADHD & Bipolar Adults Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety & Metabolic Profile of Vyvanse in ADHD & Bipolar Adults Clinical Trial page.